米国のATPアッセイ市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、セグメント別予測、2025年～2033年

米国のATPアッセイ市場規模と動向

米国のATPアッセイ市場規模は2024年に11億米ドルと推定され、2033年のCAGRは約3.87%と予測されます。

同市場は主に、創薬、臨床診断、環境モニタリング、食品安全用途において、迅速で信頼性の高い検査法に対する需要が高まっていることが背景にあります。創薬や臨床研究では、ATPアッセイは細胞生存率や細胞毒性検査で重要な役割を果たす一方、環境検査や食品品質管理では汚染検出や衛生検証をサポートします。これらのセグメントで高性能、リアルタイム分析へのニーズが高まっていることが、自動化された発光ベースATPプラットフォームの採用を後押しし続けています。

さらに、検査サンプル数の増加により、より迅速で効率的な処理をサポートする、より先進的ATPアッセイシステムの採用が進んでいます。サンプルの調製、測定、管理が改善されたことで、検査室はより効率的に作業できるようになり、遅延が減少しました。このような変化は、薬剤検査や汚染検出など、時間と正確さが重要なセグメントに恩恵をもたらしています。2024年12月、ハイジェナはNexcor Food Safety Technologies Inc.を買収し、ATPと環境モニタリング製品の品揃えを強化し、迅速で信頼性の高い検査ソリューションに対する需要の高まりをサポートします。

さらに、米国のATPアッセイ市場は、特に医薬品製造と食品品質管理において、統合化・自動化された検出システムへの顕著なシフトを目の当たりにしています。これらのプラットフォームは、迅速な検査機能とデジタル記録管理とクラウドベース分析を組み合わせることで、汚染モニタリングと規制遵守を合理化するように設計されています。標準化され、追跡可能で、高スループットのワークフローに対するニーズの高まりが、様々なセグメントでの採用を後押ししています。このシフトは、リアルタイムデータ、業務効率、進化する規制要件の遵守を重視する幅広い動向と一致しており、米国のATPアッセイ市場の継続的な拡大を後押ししています。

さらに、ヘルスケア、食品製造、環境セグメントでのバイオセーフティと品質保証基準に対する意識の高まりが、ATPアッセイ技術への持続的な投資を支えています。ラボや生産施設は、汚染リスクを最小限に抑え、FDAやUSDAなどの機関が定めた規制ガイドラインを満たすことを重視するようになっています。このため、品質管理の枠組み、特に環境モニタリングや日常的なスクリーニングのワークフローにおいて、ATP測定法の統合が進んでいます。組織がコンプライアンスと効率性を優先させる中、米国のATPアッセイ市場は、迅速で正確かつスケーラブルな検査ソリューションに対する安定した、セグメント横断的な需要から恩恵を受けると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のATPアッセイ市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国のATPアッセイ市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国のATPアッセイ市場：タイプ別、推定・動向分析

• タイプ市場シェア、2024年と2033年
• セグメントダッシュボード
• 米国のATPアッセイ市場：タイプ別展望
• 2021～2033年までの市場規模と予測と動向分析
  • 発光ATPアッセイ
  • 酵素ATPアッセイ
  • 生物発光共鳴エネルギー移動（BRET）ATPアッセイ
  • 細胞ベースATPアッセイ
  • その他

第5章 米国のATPアッセイ市場：用途別、推定・動向分析

• 用途市場シェア、2024年と2033年
• セグメントダッシュボード
• 米国のATPアッセイ市場：用途別展望
• 2021～2033年までの市場規模と予測と動向分析
  • 医薬品の発見と開発
  • 臨床診断
  • 環境検査
  • 食品の安全性と品質検査
  • その他

第6章 米国のATPアッセイ市場：最終用途別、推定・動向分析

• 最終用途市場シェア、2024年と2033年
• セグメントダッシュボード
• 米国のATPアッセイ市場：最終用途別展望
• 2021～2033年までの市場規模と予測と動向分析
  • 製薬とバイオテクノロジー企業
  • 学術研究機関
  • 病院と診断ラボ

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
  • 主要企業の市場シェア分析、2024年
  • Thermo Fisher Scientific
  • Promega Corporation
  • PerkinElmer Inc.
  • Becton, Dickinson and Company（BD）
  • Lonza Group Ltd.
  • Danaher Corporation
  • Abcam plc
  • Quest Diagnostics Incorporated
  • Biomerieux SA
  • 3M Company

List of Tables

• Table 1 List of abbreviation
• Table 2 U.S. ATP assays market, by type, 2021 - 2033 (USD Million)
• Table 3 U.S. ATP assays market, by application, 2021 - 2033 (USD Million)
• Table 4 U.S. ATP assays market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in U.S.
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. ATP Assays market: market outlook
• Fig. 10 U.S. ATP Assays competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. ATP Assays market driver impact
• Fig. 16 U.S. ATP Assays market restraint impact
• Fig. 17 U.S. ATP Assays market strategic initiatives analysis
• Fig. 18 U.S. ATP Assays market: Type movement analysis
• Fig. 19 U.S. ATP Assays market: Type outlook and key takeaways
• Fig. 20 Luminometric ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 21 Enzymatic ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 22 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 23 Cell-based ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 24 Others market estimates and forecast, 2021 - 2033
• Fig. 25 U.S. ATP Assays market: Application movement Analysis
• Fig. 26 U.S. ATP Assays market: Application outlook and key takeaways
• Fig. 27 Drug Discovery and Development market estimates and forecasts, 2021 - 2033
• Fig. 28 Clinical Diagnostics market estimates and forecasts, 2021 - 2033
• Fig. 29 Environmental Testing market estimates and forecasts, 2021 - 2033
• Fig. 30 Food Safety and Quality Testing market estimates and forecasts, 2021 - 2033
• Fig. 31 Others market estimates and forecasts, 2021 - 2033
• Fig. 32 U.S. ATP Assays market: End use movement analysis
• Fig. 33 U.S. ATP Assays market: End use outlook and key takeaways
• Fig. 34 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2021 - 2033
• Fig. 35 Academic and Research Institutes market estimates and forecasts, 2021 - 2033
• Fig. 36 Hospital and Diagnostics Laboratories market estimates and forecasts, 2021 - 2033
• Fig. 37 U.S. ATP Assays market share and leading players
• Fig. 38 U.S. market share and leading players
• Fig. 39 U.S. market estimates and forecasts, 2021 - 2033
• Fig. 40 Market share of key market players - U.S. ATP Assays market

U.S. ATP Assays Market Size & Trends:

The U.S. ATP assays market size was estimated at USD 1.10 billion in 2024 and is projected to register a CAGR of around 3.87% through 2033. The market is primarily driven by increasing demand for rapid, reliable testing methods across drug discovery, clinical diagnostics, environmental monitoring, and food safety applications. In drug development and clinical research, ATP assays play a key role in cell viability and cytotoxicity studies, while their use in environmental testing and food quality control supports contamination detection and hygiene verification. The growing need for high throughput, real time analysis across these sectors continues to support adoption of automated, luminescence based ATP platforms.

In addition, the rising number of samples being tested has led to the adoption of more advanced ATP assay systems that support faster and more efficient processing. Improvements in preparing, measuring, and managing samples have helped laboratories work more effectively and reduce delays. These changes benefit areas such as drug testing and contamination detection, where time and accuracy matter. In December 2024, Hygiena acquired Nexcor Food Safety Technologies Inc., strengthening its range of ATP and environmental monitoring products and supporting the growing demand for quick, reliable testing solutions.

Moreover, the U.S. ATP Assays market is witnessing a notable shift toward integrated and automated detection systems, particularly in pharmaceutical manufacturing and food quality control. These platforms are designed to streamline contamination monitoring and regulatory compliance by combining rapid testing capabilities with digital record-keeping and cloud-based analytics. The growing need for standardized, traceable, and high-throughput workflows drives adoption across various sectors. This shift aligns with broader trends emphasizing real-time data, operational efficiency, and adherence to evolving regulatory requirements, reinforcing the continued expansion of the U.S. ATP Assays market.

Furthermore, growing awareness of biosafety and quality assurance standards across healthcare, food production, and environmental sectors supports sustained investment in ATP assay technologies. Laboratories and production facilities are placing increased emphasis on minimizing contamination risks and meeting regulatory guidelines set by agencies such as the FDA and USDA. This has led to greater integration of ATP assays within quality control frameworks, particularly within environmental monitoring and routine screening workflows. With organizations prioritizing compliance and efficiency, the U.S. ATP Assays market is expected to benefit from stable, cross-sector demand for fast, accurate, and scalable testing solutions.

U.S. ATP Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. ATP assays market on the test type,application, and end use:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Luminometric ATP Assays
• Enzymatic ATP Assays
• Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
• Cell-based ATP Assays
• Others
• Application Outlook (Revenue, USD Million, 2021- 2033)
• Drug Discovery and Development
• Clinical Diagnostics
• Environmental Testing
• Food Safety and Quality Testing
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospital and Diagnostics Laboratories

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in U.S.
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. ATP Assays market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising emphasis on cell-based research in drug development
    • 3.2.1.2. Increased adoption in food and beverage industry for hygiene monitoring
    • 3.2.1.3. Expansion of biomanufacturing and bioprocess monitoring
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited specificity in complex biological samples
    • 3.2.2.2. Availability of alternative assay techniques
• 3.3. U.S. ATP Assays market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. ATP Assays market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2024 & 2033
• 4.2. Segment Dashboard
• 4.3. U.S. ATP Assays market by Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.4.1. Luminometric ATP Assays
    • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Enzymatic ATP Assays
    • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
    • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.4. Cell-based ATP Assays
    • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. ATP Assays market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2033
• 5.2. Segment Dashboard
• 5.3. U.S. ATP Assays market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.4.1. Drug Discovery and Development
    • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Clinical Diagnostics
    • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Environmental Testing
    • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Food Safety and Quality Testing
    • 5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. ATP Assays market: End use Estimates & Trend Analysis

• 6.1. End use Market Share, 2024 & 2033
• 6.2. Segment Dashboard
• 6.3. U.S. ATP Assays market by End use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.4.1. Pharmaceutical and Biotechnology Companies
    • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.2. Academic and Research Institutes
    • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.3. Hospital and Diagnostics Laboratories
    • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Thermo Fisher Scientific
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Promega Corporation
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. PerkinElmer Inc.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Becton, Dickinson and Company (BD)
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Lonza Group Ltd.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Danaher Corporation
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Abcam plc
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Quest Diagnostics Incorporated
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Biomerieux SA
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. 3M Company
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives